Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 228 results for "ranbaxy industries"

Ranbaxy whistle blower Dinesh Thakur suggests strict prosecuti...

NEW DELHI: Dinesh Thakur, the famous whistle blower who highlighted data manipulation issues at top Indian drug maker Ranbaxy (now part of Sun Pharma), says the country needs strict criminal prosecution against suppliers of substandard drugs, a ... Economic Times, 2 months ago

4 images for ranbaxy industries, 1 week ago
The Freepress Journal, 1 month ago
Money Today, 5 months ago
Money Control, 6 months ago

Sun Pharma Q1 net zooms over 3-fold at Rs 2,034 cr on strong US sales

A man carrying a gas cylinder walks out of the research and development centre of Sun Pharmaceutical Industries in Mumbai. Photo: Reuters Sun Pharmaceutical Industries posted 3.6 per cent times growth in consolidated net profit in Q1FY17 on a ...
 Business Standard India2 weeks ago Sun Pharma Q1 net jumps over three times  The Hindu2 weeks ago Buy Sun Pharmaceutical Industries Ltd., target Rs 925.0 : Motilal Oswal Securities  Economic Times3 weeks ago Sun Pharma profit triples to Rs2,034 crore in Q1 on higher sales of cancer drug  Livemint.com2 weeks ago

Ranbaxy-Daiichi affair: How & why the deal went south

The Singapore International Arbitration Centre's (SIAC's) order in the Ranbaxy-Daiichi case has revealed in detail how the Indian pharmaceutical major withheld pertinent information from Japan's Daiichi-Sankyo, reported The Indian Express on ...
 Smart Investor2 weeks ago

Sun Pharma brings back old hand Kalyanasundaram Subramanian from Taro Pharmaceutical Industries

MUMBAI: Kalyanasundaram Subramanian, or Kal Sundaram, an old hand at Sun Pharmaceutical Industries, is coming back home. He will be leading the India and sub-continent business starting January 2017. Post the acquisition of Ranbaxy, Sun has taken ...
 Economic Times1 month ago Suven Life gets patent and other top pharma news  India Infoline1 month ago

Pharma M&As: value creator or value destroyer?

Anil Khanna , Partner, Tai Pi Advisors analyses the trend of rising M&As in the pharma industry and examines its causes and implications Anil Khanna What is it with M&As that they make the adrenalin skyrocket, or generate a strong urge to go ...
 Express Pharma1 month ago

Mumbai court directs Sun Pharma to pay pending wages to 86 employees

Mumbai court holds Sun Pharma responsible for committing unfair labour practices after its merger with Ranbaxy Laboratories in March 2015 Mumbai: India's largest drug maker Sun Pharmaceutical Industries Ltd has suffered a setback in its tussle with ...
 Livemint.com4 weeks ago

Taro Pharma: Seeking A Catalyst

Intro: Why should we be interested? Taro Pharmaceutical Industries Ltd (NYSE: TARO ) is a stock that'll show up on value screens due to a) its stellar operating performance over the past several years, and b) its cheap price (~ 11x PE) in a ...
 Seeking Alpha1 month ago Sun names Abhay Gandhi CEO of North America ops  FiercePharma1 month ago India's Sun brings Taro CEO to headquarters  FiercePharma1 month ago

Industry moves digest: Zee Media, Housing, Snapdeal, LeEco & more

Pooja Gupta quits as marketing head of Zee Media The marketing head of Zee Media Corp Ltd (ZMCL), Pooja Gupta has put down her papers, she was promoted to the role in November 2015. Prior to her role at Zee Media, Gupta worked with media houses ...
 Media Nama1 month ago

Reliance Life gains global rights for copies of Infliximab

MUMBAI: Reliance Life Sciences, the biopharmaceutical unit of Reliance Industries, has acquired the global rights for biosimilars, or copies, of Infliximab from Boston based Epirus Biopharmaceuticals. Infliximab is used to treat a broad range of ...
 Economic Times1 month ago India's Reliance Grabs Rights to Biosimilars in Epirus Bankruptcy  Pharmaceutical Manufacturing Magazine1 month ago

Mylan says Indian drug industry needs more transparency from FDA

Rajiv Malik of Mylan's says the Indian pharmaceutical industry is working with the FDA to make the resolution of the regulatory issues more transparent Toronto: Mylan NV president Rajiv Malik said the Indian drug industry is starting to get ...
 Livemint.com2 months ago 'Frustrated'  Bloomberg2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less